Identification of STX-241, a CNS-penetrant and mutant-selective EGFR inhibitor with activity on osimertinib-resistant C797x mutations

被引：1
|
作者：
Pagliarini, Raymond A.
Milgram, Benjamin C.
Borrelli, Deanna R.
O'Hearn, Erin
Huff, Michael R.
Ladd, Brendon
Brooijmans, Natasja
Wang, Weixue
Kuzmic, Petr
Guzman-Perez, Angel
Stuart, Darrin D.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-B168
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B168
引用
收藏
页数：2
相关论文
共 4 条
  • [1] BDTX-1535, a CNS penetrant MasterKey inhibitor of common, uncommon and resistant EGFR mutations, demonstrates in vivo efficacy and has potential to treat osimertinib-resistant NSCLC with or without brain metastases
    Lucas, Matthew C.
    Merchant, Melinda S.
    O'Connor, Matthew
    Cook, Carl
    Smith, Sherri
    Trombino, Anthony
    Zhang, Wu-Yan
    Visiers, Irache
    Tith, Kate
    Foroughi, Reza
    Waters, Nigel
    Wrona, Iwona
    Pickard, Michael
    Eathiraj, Sudharshan
    Witt, Karsten
    Roberts, Christopher
    Humphrey, Rachel
    Buck, Elizabeth
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [2] TRX-221, a 4th generation, mutant-selective, and CNS-active EGFR inhibitor with robust antitumor activity in osimertinibresistant tumor models harboring C797S mutation
    Lim, S.
    Choi, S.
    Lee, J.
    Kim, S.
    Choi, E.
    Lee, S.
    Chun, K.
    Lee, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1198 - S1198
  • [3] Preclinical characterization of CNS-active, mutant-selective fourth-generation EGFR inhibitors with potent activity against single, double, and triple mutant EGFR variants including T790M and C797S
    Zhang, S.
    Huang, W. S.
    Nadworny, S.
    Ye, E.
    Narasimhan, N.
    Eyermann, C. J.
    Dalgarno, D.
    Rivera, V.
    Shakespeare, W.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S85 - S85
  • [4] Preclinical characterization of THE-349, a mutant-selective, CNS-active, fourth-generation EGFR inhibitor to overcome T790M-and C797S-mediated resistance in NSCLC
    Zhang, Sen
    Nadworny, Sara
    Huang, Wei-Sheng
    Talbot, Adam
    Ye, Emily
    Narasimhan, Narayana
    Shakespeare, William C.
    Rivera, Victor M.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
1